Literature DB >> 16862395

Pyridostigmine in autonomic failure: can we treat postural hypotension and bladder dysfunction with one drug?

Tatsuya Yamamoto1, Ryuji Sakakibara, Yoshitaka Yamanaka, Tomoyuki Uchiyama, Masato Asahina, Zhi Liu, Takashi Ito, Yu Koyama, Yusuke Awa, Kaori Yamamoto, Mika Kinou, Takamichi Hattori.   

Abstract

In a 66-year-old man with autonomic failure, pyridostigmine (180 mg/day orally) improved both postural hypotension and underactive detrusor bladder dysfunction. Acetylcholinesterase inhibition may be useful in the management of orthostatic hypotension and bladder dysfunction in autonomic failure patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16862395     DOI: 10.1007/s10286-006-0358-z

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   5.625


  13 in total

1.  Micturitional disturbance in pure autonomic failure.

Authors:  R Sakakibara; T Hattori; T Uchiyama; M Asahina; T Yamanishi
Journal:  Neurology       Date:  2000-01-25       Impact factor: 9.910

2.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

3.  Sphincter electromyography in diagnosis of multiple system atrophy: technical issues.

Authors:  Simon Podnar; Clare J Fowler
Journal:  Muscle Nerve       Date:  2004-01       Impact factor: 3.217

4.  Cutaneous sympathetic function in patients with multiple system atrophy.

Authors:  Masato Asahina; Yuriko Kikkawa; Atsuya Suzuki; Takamichi Hattori
Journal:  Clin Auton Res       Date:  2003-04       Impact factor: 4.435

5.  Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor.

Authors:  Tomonori Yamanishi; Kosaku Yasuda; Takao Kamai; Toshihiko Tsujii; Ryuji Sakakibara; Tomoyuki Uchiyama; Ken-ichiro Yoshida
Journal:  Int J Urol       Date:  2004-02       Impact factor: 3.369

6.  Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study.

Authors:  Paola Sandroni; Tonette L Opfer-Gehrking; Wolfgang Singer; Phillip A Low
Journal:  Clin Auton Res       Date:  2005-02       Impact factor: 4.435

7.  Symptomatic and urodynamic improvement by oral distigmine bromide in poor voiders after transurethral resection of the prostate.

Authors:  Y Tanaka; N Masumori; N Itoh; S Furuya; O Nishizawa; T Tsukamoto
Journal:  Urology       Date:  2001-02       Impact factor: 2.649

8.  [A case of pure autonomic failure (PAF) with sleep apnea syndrome (SAS) and successful treatment of dysautonomia with nasal continuous positive airway pressure (CPAP)].

Authors:  Eri Hamada; Kensho Okamoto; Bungo Okuda
Journal:  Nihon Ronen Igakkai Zasshi       Date:  2004-03

9.  Multiple system atrophy: an update.

Authors:  Gregor K Wenning; Felix Geser; Michaela Stampfer-Kountchev; François Tison
Journal:  Mov Disord       Date:  2003-09       Impact factor: 10.338

10.  Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies.

Authors:  Horacio Kaufmann; Kirsty Nahm; Dushyant Purohit; David Wolfe
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

View more
  3 in total

Review 1.  Urological dysfunction in synucleinopathies: epidemiology, pathophysiology and management.

Authors:  Ryuji Sakakibara; Fuyuki Tateno; Tatsuya Yamamoto; Tomoyuki Uchiyama; Tomonori Yamanishi
Journal:  Clin Auton Res       Date:  2017-11-09       Impact factor: 4.435

2.  Orthostatic responses to anticholinesterase inhibition in spinal cord injury.

Authors:  Jill M Wecht; Christopher M Cirnigliaro; Frank Azarelo; William A Bauman; Steven C Kirshblum
Journal:  Clin Auton Res       Date:  2015-04-28       Impact factor: 4.435

3.  Pilot study of pyridostigmine in constipated patients with autonomic neuropathy.

Authors:  Adil E Bharucha; Phillip A Low; Michael Camilleri; Duane Burton; Tonette L Gehrking; Alan R Zinsmeister
Journal:  Clin Auton Res       Date:  2008-07-11       Impact factor: 4.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.